Health Viewpoints

Steroids: Too Little Too Late in COVID-19 Respiratory Illness

Steroids: Too Little Too Late in COVID-19 Respiratory Illness
Fred Tanneau/AFP via Getty Images
Dr. Peter A. McCullough
&
John Leake
|Updated:
0:00

To this day, the Infectious Disease Society of America and the National Institutes of Health Guidelines do not advise prehospital use of corticosteroids in COVID-19 illness.

Conversely oral and or nebulized steroids have been a part of the FLCCC and McCullough protocols since 2020. Justification for early steroids sadly comes from an autopsy study of fatal cases by Kato et al who evaluated 61 cases from the NIH, Cornell, and University of North Carolina Chapel Hill.

Dr. McCullough is a practicing internist, cardiologist, and epidemiologist in Dallas, Texas. He studies the cardiovascular complications of both the viral infection and the injuries developed from COVID vaccines. He has dozens of peer-reviewed publications on COVID, multiple U.S. and state Senate testimonies, and has commented extensively on the medical response to the COVID crisis on major media outlets.
Related Topics